Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
Clinical trial NCT00193622 · COMPLETED
Trial details
- NCT number
- NCT00193622
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.